NCT03401918View on ClinicalTrials.gov

Assessing the Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

July 1, 2021

Study Completion Date

July 1, 2021

Conditions
Recurrent Pregnancy LossUnexplained Infertility
Interventions
DIAGNOSTIC_TEST

Uterine ERA and microbiome testing

Uterine fluid and endometrial biopsy collection to test uterine endometrial receptivity array and microbiome.

DRUG

Oral antibiotics and vaginal probiotics

For subjects with abnormal microbiome results, oral antibiotics and vaginal probiotic treatment will be offered followed by a repeat uterine microbiome biopsy.

Trial Locations (1)

94087

Reproductive Endocrinology and Infertility Center at Stanford University, Sunnyvale

All Listed Sponsors
collaborator

Instituto Valenciano de Infertilidad, IVI VALENCIA

OTHER

lead

Stanford University

OTHER

NCT03401918 - Assessing the Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility | Biotech Hunter | Biotech Hunter